Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery and delivery of next-generation preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make seamless, person-centered care the standard in Central Texas and beyond.
Get Care
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Amy Durand, M.D.

Education

MD
McGovern Medical School at UTHealth Houston

BS, Biology
Texas A&M University

Residency/Fellowship

Residency, Neurology
UTHealth Houston

About

Amy Durand, MD, is a board-certified neuro-ophthalmologist in UT Medicine’s Mitchel and Shannon Wong Eye Institute. She specializes in the diagnosis and treatment of a wide range of visual disorders caused by neurologic diseases, including optic nerve abnormalities such as optic neuritis and ischemic optic neuropathy, visual field deficits, pupillary asymmetry, double vision, and eye movement disorders. Additionally, Durand is an assistant professor in the Department of Ophthalmology at Dell Medical School at The University of Texas at Austin.

Dr. Durand earned her bachelor’s degree in biology from Texas A&M University, where she graduated magna cum laude, and her medical degree from McGovern Medical School at UTHealth Houston. She completed a residency in neurology at UTHealth Houston, where she served as chief resident, and a fellowship in neuro-ophthalmology at the University of Pennsylvania at Scheie Eye Institute, Perelman Center, and the Children’s Hospital of Pennsylvania.

Dr. Durand has been invited to present her research at local, national, and international conferences. Her work primarily focuses on neuro-ophthalmology, including idiopathic intracranial hypertension, optic nerve sheath fenestration, and orbital inflammatory disease, with additional contributions in stroke recovery outcomes. She is an active member of the American Academy of Neurology and the North American Neuro-Ophthalmology Society.